Molecular classification of hormone receptor-positive HER2-negative breast cancer-Reference-Cited by-同舟云学术

Molecular classification of hormone receptor-positive HER2-negative breast cancer

Published:2023-09-28 Issue:10 Volume:55 Page:1696-1708
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Jin Xi,Zhou Yi-Fan,Ma Ding^ORCID,Zhao Shen,Lin Cai-Jin^ORCID,Xiao Yi,Fu Tong,Liu Cheng-Lin,Chen Yi-Yu,Xiao Wen-Xuan,Liu Ya-Qing^ORCID,Chen Qing-Wang^ORCID,Yu Ying^ORCID,Shi Le-Ming^ORCID,Shi Jin-Xiu,Huang Wei^ORCID,Robertson John F. R.,Jiang Yi-Zhou^ORCID,Shao Zhi-Ming^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

https://www.nature.com/articles/s41588-023-01507-7.pdf

Reference87 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).

2. Huppert, L. A., Gumusay, O., Idossa, D. & Rugo, H. S. Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer. CA Cancer J. Clin. 73, 480–515 (2023).

3. Ma, C. X., Reinert, T., Chmielewska, I. & Ellis, M. J. Mechanisms of aromatase inhibitor resistance. Nat. Rev. Cancer 15, 261–275 (2015).

4. Dowsett, M. et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J. Clin. Oncol. 28, 509–518 (2010).

5. Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836–1846 (2017).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy;The Breast;2024-12

2. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice;Precision Medicine and Engineering;2024-09

3. Application and prospect of organoid technology in breast cancer;Frontiers in Immunology;2024-08-26

4. Three-Dimensional Visualization of Breast Cancer Pathology Evolution in Clinical Patient Tissues with NIR-II Imaging;Nano Letters;2024-08-09

5. Artificial intelligence methods available for cancer research;Frontiers of Medicine;2024-08-08